BIOLASE financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$60.65M $61.98M $69.70M $66.89M $64.63M $43.35M $26.23M $48.86M $57.36M $55.99M $47.35M $48.11M $51.81M $46.93M $46.16M $37.80M $22.78M $39.19M $48.46M $49.16M $0.00M
GM % Gross Margin %
59.37% 49.90% 52.35% 51.62% 50.54% 46.28% 33.65% 43.63% 46.16% 37.67% 37.73% 32.40% 39.20% 32.23% 36.60% 37.80% 27.10% 42.18% 32.83% 34.02% 0.00%
OM Operating Margin
-3.63% -27.53% -6.45% -12.21% -10.78% -6.83% -43.70% -8.20% -4.41% -19.64% -37.89% -42.91% -28.88% -37.36% -39.43% -41.33% -81.37% -42.66% -52.28% -34.04% 0.00%
EPS Earnings Per Share
$-7809.78 $-2067.30 $-3100.94 $-3445.49 $-689.10 $-5627.64 $-1740.11 $-1219.21 $-4353.23 $-5625.00 $-4198.75 $-3625.00 $-2250.00 $-1775.00 $-1448.50 $-1400.00 $-303.50 $-342.14 $-27.53 $0.00
Div. Dividends
$344.55 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
-75.00% 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
5.31m 5.06m 5.15m 5.2m 5.28m 5.3m 5.35m 6.4m 6.41m 7.07m 11.62m 11.65m 13.51m 20.46m 20.65m 30.95m 93.51m 0.06m 0.08m 3.42m 33.26m
OCF Operating Cash Flow
$-1.57M $-17.05M $0.43M $-3.27M $-4.52M $-2.57M $-3.81M $-13.32M $-1.66M $-9.30M $-16.20M $-17.77M $-10.60M $-18.41M $-14.15M $-12.75M $-12.80M $-16.71M $-26.76M $-14.09M $0.00M
FCF Free Cash Flow
$-3.00M $-18.91M $-1.90M $-4.05M $-5.50M $-3.02M $-4.05M $-13.75M $-2.47M $-9.97M $-16.40M $-19.57M $-12.01M $-19.16M $-14.71M $-12.96M $-12.90M $-17.42M $-30.49M $-16.42M $0.00M
FCFS Free Cash Flow Per Share
$-0.61 $-3.77 $-0.37 $-0.80 $-1.05 $-0.57 $-0.76 $-2.24 $-0.39 $-1.52 $-1.94 $-1.68 $-0.99 $-1.30 $-0.71 $-0.56 $-0.21 $-2.95 $-439.94 $-12.05 $0.00